Alps Group Inc has announced that it has successfully regained compliance with the minimum bid price requirement set by Nasdaq. This update is crucial for the company as it ensures its continued listing on The Nasdaq Global Market, a significant achievement for the integrated biotechnology platform.

On November 20, 2026, the company received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that it had met the necessary requirements. This news comes after a challenging period for the company, which had previously faced potential delisting.

Background

Alps Group Inc operates within the health services sector under the SIC code 8000. The company is listed on Nasdaq under the ticker symbol ALPS and also trades on the OTC market as ALPWF. As an emerging growth company, Alps Group is focused on providing innovative biotechnology solutions, including cell manufacturing and molecular diagnostics.

What the Filing Says

The recent filing states, "Alps Group Inc has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market." This statement underscores the company's efforts to stabilize its stock price and maintain its market presence.

Impact

This development may positively affect shareholders and stakeholders who rely on the company's performance. Compliance with Nasdaq's listing requirements is essential for maintaining investor confidence and attracting potential investors.

What's Next

The filing does not specify any upcoming actions or further filings following this compliance confirmation. However, the company is expected to continue its efforts to strengthen its market position and enhance shareholder value.